ISO-24190 › Biotechnology - Analytical methods - Risk-based approach for method selection and validation for rapid microbial detection in bioprocesses
The following bibliographic material is provided to assist you with your purchasing decision:
This document provides guidance, a framework and a risk-based approach for the selection and validation of methods for rapid microbial detection in cellular therapeutic product manufacturing.
This document provides a flexible risk-based framework for the detection of microbial contamination in cellular therapeutic products and cellular intermediates.
This document provides general requirements and risks associated with cellular therapeutic product manufacturing, with flexibility to address differences in specific manufacturing processes of each unique cellular therapeutic product.
This document primarily addresses sterility testing in cellular therapeutic product manufacturing. This document is applicable to other cell-derived therapeutic product manufacturing.
This document focuses on rapid microbial test methods (RMTMs) used for both in-process and final product testing.
Viral testing in cellular therapeutic product manufacturing is not included in this document.
To find similar documents by classification:
07.080 (Biology. Botany. Zoology Including biotechnology)
This document comes with our free Notification Service, good for the life of the document.
This document is available in either Paper or PDF format.
Document Number
ISO 24190:2023
Revision Level
1ST EDITION
Status
Current
Publication Date
May 1, 2023
Committee Number
ISO/TC 276